The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Thiazole-containing compounds as therapeutic targets for cancer therapy
Open accessAbstract
In the last few decades, considerable progress has been made in anticancer agents development, and several new anticancer agents of natural and synthetic origin have been produced. Among heterocyclic compounds, thiazole, a 5-membered unique heterocyclic motif containing sulphur and nitrogen atoms, serves as an essential core scaffold in several medicinally important compounds. Thiazole nucleus is a fundamental part of some clinically applied anticancer drugs, such as dasatinib, dabrafenib, ixabepilone, patellamide A, and epothilone. Recently, thiazole-containing compounds have been successfully developed as possible inhibitors of several biological targets, including enzyme-linked receptor(s) located on the cell membrane, (i.e., polymerase inhibitors) and the cell cycle (i.e., microtubular inhibitors). Moreover, these compounds have been proven to exhibit high effectiveness, potent anticancer activity, and less toxicity. This review presents current research on thiazoles and elucidates their biological importance in anticancer drug discovery. The findings may aid researchers in the rational design of more potent and bio-target specific anticancer drug molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Cellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
Microtubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,718
Katzung, B. G. (2018) · Cited by 1,377
Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049486a · Cited by 1,297
The protein tyrosine kinase family of the human genome
Robinson, D. R., Wu, Y.-M., & Lin, S.-F. (2000) · Oncogene · doi:10.1038/sj.onc.1203957 · Cited by 1,167
Targeting the EGFR signaling pathway in cancer therapy
Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K., & Batra, S. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.648617 · Cited by 913
DNA topoisomerase II and its growing repertoire of biological functions
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2608 · Cited by 885
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
(2005) · Advances in Cancer Research · doi:10.1016/s0065-230x(05)94002-5 · Cited by 823
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018866109 · Cited by 663
Mechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Targeted therapies: a new generation of cancer treatments.
Gerber, D. E. (2008) · PubMed · Cited by 638
Tyrosine kinase – Role and significance in Cancer
Paul, M. K., & Mukhopadhyay, A. K. (2004) · International Journal of Medical Sciences · doi:10.7150/ijms.1.101 · Cited by 624
Targeting Microtubules by Natural Agents for Cancer Therapy
Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0791 · Cited by 565
Receptor tyrosine kinases: mechanisms of activation and signaling
Hubbard, S. R., & Miller, W. T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.010 · Cited by 531
The Akt kinases: Isoform specificity in metabolism and cancer
Gonzalez, E., & McGraw, T. E. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9335 · Cited by 472
Recent developments and biological activities of thiazolidinone derivatives: A review
Jain, A. K., Vaidya, A., Ravichandran, V., Kashaw, S. K., & Agrawal, R. K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.069 · Cited by 461
An overview of targeted cancer therapy
Padma, V. V. (2015) · BioMedicine · doi:10.7603/s40681-015-0019-4 · Cited by 459
Ayati, A., Emami, S., Asadipour, A., Shafiee, A., & Foroumadi, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.015 · Cited by 449
Microtubules and Their Role in Cellular Stress in Cancer
Parker, A. L., Kavallaris, M., & McCarroll, J. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00153 · Cited by 440
Receptor tyrosine kinase signalling as a target for cancer intervention strategies.
Zwick, E., Bange, J., & Ullrich, A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080161 · Cited by 384
Hutchinson, I., Chua, M.-S., Browne, H. L., Trapani, V., Bradshaw, T. D., Westwell, A. D., & Stevens, M. F. G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001104n · Cited by 354
Van der Veldt, A. A. M., Lubberink, M., Bahce, I., Walraven, M., de Boer, M. P., Greuter, H. N. J. M., Hendrikse, N. H., Eriksson, J., Windhorst, A. D., Postmus, P. E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.023 · Cited by 337
The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
J. Boohaker, R., W. Lee, M., Vishnubhotla, P., M. Perez, J. L., & R. Khaled, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661004 · Cited by 302
Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives
Refaat, H. M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.03.022 · Cited by 279
Medicinal significance of benzothiazole scaffold: an insight view
Sharma, P. C., Sinhmar, A., Sharma, A., Rajak, H., & Pathak, D. P. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.720572 · Cited by 256
Self-citationCarlsson, J., Nordgren, H., Sjöström, J., Wester, K., Villman, K., Bengtsson, N. O., Ostenstad, B., Lundqvist, H., & Blomqvist, C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601881 · Cited by 225
Synthesis, anticancer activity and mechanism of action of new thiazole derivatives
de Santana, T. I., Barbosa, M. D. O., Gomes, P. A. T. D. M., da Cruz, A. C. N., da Silva, T. G., & Leite, A. C. L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.040 · Cited by 217
Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
Bondock, S., Adel, S., Etman, H. A., & Badria, F. A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.12.013 · Cited by 213
Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin
Wieland Brown, L. C., Acker, M. G., Clardy, J., Walsh, C. T., & Fischbach, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900008106 · Cited by 189
Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Morinaga, Y., Akiyama, Y., & Tsuji, T. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00579-4 · Cited by 185
Lü, Y., Li, C., Wang, Z., Ross, C. R., Chen, J., Dalton, J. T., Li, W., & Miller, D. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801449a · Cited by 182
Thiopeptide Antibiotics: Retrospective and Recent Advances
Just-Baringo, X., Albericio, F., & Álvarez, M. (2014) · Marine Drugs · doi:10.3390/md12010317 · Cited by 179
Glycolytic enzyme inhibitors in cancer treatment
Scatena, R., Bottoni, P., Pontoglio, A., Mastrototaro, L., & Giardina, B. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1533 · Cited by 164
Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles
Desai, N. C., Bhatt, N., Somani, H., & Trivedi, A. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.029 · Cited by 163
Peptide-Based Treatment: A Promising Cancer Therapy
Xiao, Y.-F., Jie, M.-M., Li, B.-S., Hu, C.-J., Xie, R., Tang, B., & Yang, S.-M. (2015) · Journal of Immunology Research · doi:10.1155/2015/761820 · Cited by 163
Li, X., He, Y., Ruiz, C. H., Koenig, M., & Cameron, M. D. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025932 · Cited by 163
Lv, P.-C., Li, D.-D., Li, Q.-S., Lu, X., Xiao, Z.-P., & Zhu, H.-L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.010 · Cited by 162
New Antitumor Imidazo[2,1- b ]thiazole Guanylhydrazones and Analogues 1
Andreani, A., Burnelli, S., Granaiola, M., Leoni, A., Locatelli, A., Morigi, R., Rambaldi, M., Varoli, L., Calonghi, N., Cappadone, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701246g · Cited by 156
Hayakawa, M., Kaizawa, H., Kawaguchi, K.-I., Ishikawa, N., Koizumi, T., Ohishi, T., Yamano, M., Okada, M., Ohta, M., Tsukamoto, S., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.047 · Cited by 138
Luzina, E. L., & Popov, A. V. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.08.007 · Cited by 128
Lv, P., Zhou, C., Chen, J., Liu, P., Wang, K., Mao, W., Li, H., Yang, Y., Xiong, J., & Zhu, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.051 · Cited by 127
Gaillard, S. L., & Stearns, V. (2011) · Breast Cancer Research · doi:10.1186/bcr2818 · Cited by 126
Ramla, M. M., Omar, M. A., Tokuda, H., & Diwani, H. I. E. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.010 · Cited by 118
Cai, J., Sun, M., Wu, X., Chen, J., Wang, P., Zong, X., & Ji, M. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.013 · Cited by 113
Park, J., El-Gamal, M. I., Lee, Y. S., & Oh, C. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.08.024 · Cited by 110
Natural Products as Aromatase Inhibitors
Balunas, M. J., Su, B., Brueggemeier, R. W., & Kinghorn, A. D. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785133092 · Cited by 109
Drug Targets for Cancer Treatment: An Overview
Kumar, S. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000252 · Cited by 109
Rajak, H., Agarawal, A., Parmar, P., Thakur, B. S., Veerasamy, R., Sharma, P. C., & Kharya, M. D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.022 · Cited by 108
Self-citationSharma, P., Reddy, T. S., Thummuri, D., Senwar, K. R., Kumar, N. P., Naidu, V. G. M., Bhargava, S. K., & Shankaraiah, N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.029 · Cited by 106
Self-citationSynthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives
Kurt, B. Z., Gazioğlu, I., Sönmez, F., & Küçükislamoğlu, M. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.02.002 · Cited by 105
Yan, L., Rosen, N. X., & Arteaga, C. L. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10553 · Cited by 104
Promising molecular targeted therapies in breast cancer
Munagala, R., Aqil, F., & Gupta, R. C. (2011) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.81497 · Cited by 92
Zablotskaya, A., Segal, I., Geronikaki, A. A., Eremkina, T., Belyakov, S., Petrova, M. V., Shestakova, I., Zvejniece, L., & Nikolajeva, V. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.008 · Cited by 88
Altıntop, M. D., Özdemır, A., Turan‐Zitouni, G., Ilgın, S., Atlı, Ö., Demirel, R., & Kaplancıklı, Z. A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.055 · Cited by 87
Zeng, X., Yin, B., Hu, Z., Liao, C., Liu, J., Li, S., Li, Z., Nicklaus, M. C., Zhou, G., & Jiang, S. (2010) · Organic Letters · doi:10.1021/ol100308a · Cited by 85
Andreani, A., Granaiola, M., Leoni, A., Locatelli, A., Morigi, R., Rambaldi, M., Lenaz, G., Fato, R., Bergamini, C., & Farruggia, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040888s · Cited by 80
Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors
Andreani, A., Granaiola, M., Leoni, A., Locatelli, A., Morigi, R., Rambaldi, M., Varoli, L., Lannigan, D. A., Smith, J., Scudiero, D. A., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.001 · Cited by 79
Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors
Chen, C., Song, J.-M., Wang, J., Xu, C., Chen, C., Gu, W. J., Sun, H., & Wen, X. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.018 · Cited by 79
Design, synthesis and antimalarial evaluation of novel thiazole derivatives
Bueno, J. M., Cardá, M., Crespo, B., Cuñat, A. C., de Cózar, C., León, M. L., Marco, J. A., Roda, N., & Sanz‐Cervera, J. F. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.010 · Cited by 78
Cheng, Y., Avula, S. R., Gao, W., Addla, D., Tangadanchu, V. K. R., Zhang, L., Lin, J.-M., & Zhou, C. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.011 · Cited by 78
Lotfy, G., Said, M. M., Ashry, E. S. H. E., Tamany, E. S. H. E., Al‐Dhfyan, A., Aziz, Y. M. A., & Barakat, A. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.01.014 · Cited by 77
Concerning the Mode of Action of Micrococcin upon Bacterial Protein Synthesis
Cundliffe, E., & Thompson, J. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb05484.x · Cited by 75
Vaarla, K., Kesharwani, R. K., Karnewar, S., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.042 · Cited by 73
Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors
Secci, D., Carradori, S., Bizzarri, B., Bolasco, A., Ballario, P., Patramani, Z., Fragapane, P., Vernarecci, S., Canzonetta, C., & Filetici, P. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.01.022 · Cited by 72
Hassan, G. S., El‐Messery, S. M., Al-Omary, F. A. M., Al‐Rashood, S. T., Shabayek, M. I., Abulfadl, Y. S., Habib, E. E., El-hallouty, S. M., Fayad, W., Mohamed, K. M., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.05.039 · Cited by 72
Rajak, H., Singh, A. J., Raghuwanshi, K. K., Kumar, R., Dewangan, P. K., Veerasamy, R., Sharma, P. C., Dixit, A., & Mishra, P. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990191 · Cited by 71
Self-citationZhao, M., Yin, Y., Yu, X., Sangani, C. B., Wang, S.-F., Lu, A., Yang, L., Lv, P., Jiang, M., & Zhu, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.029 · Cited by 69
Altıntop, M. D., Sever, B., Çiftçi, G. A., & Özdemır, A. (2018) · Molecules · doi:10.3390/molecules23061318 · Cited by 69
Novel thiazole derivatives: a patent review (2008 – 2012. Part 2)
Leoni, A., Locatelli, A., Morigi, R., & Rambaldi, M. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.910196 · Cited by 69
Shaik, S. P., Nayak, V., Sultana, F., Rao, A., Shaik, A. B., Babu, K. S., & Kamal, Ä. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.060 · Cited by 68
Rao, A., Swapna, K., Shaik, S. P., Nayak, V., Reddy, T. S., Sunkari, S., Shaik, T. B., Bagul, C., & Kamal, Ä. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.010 · Cited by 68
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes
Grozav, A., Bălăcescu, O., Bălăcescu, L., Cheminel, T., Berindan‐Neagoe, I., & Therrien, B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00855 · Cited by 67
Fallah‐Tafti, A., Foroumadi, A., Tiwari, R. K., Shirazi, A. N., Hangauer, D. G., Bu, Y., Akbarzadeh, T., Parang, K., & Shafiee, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.050 · Cited by 66
Patellamide F, a New Cytotoxic Cyclic Peptide from the Colonial Ascidian Lissoclinum patella
Rashid, M. A., Gustafson, K. R., Cardellina, J. H., & Boyd, M. R. (1995) · Journal of Natural Products · doi:10.1021/np50118a020 · Cited by 66
Manikandamathavan, V. M., Thangaraj, M., Weyhermüller, T., Parameswari, R. P., Punitha, V., Murthy, N. N., & Nair, B. U. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.030 · Cited by 66
Romagnoli, R., Baraldi, P. G., Salvador, M. K., Camacho, M. E., Preti, D., Tabrizi, M. A., Bassetto, M., Brancale, A., Hamel, E., Bortolozzi, R., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.001 · Cited by 64
Carradori, S., Rotili, D., Monte, C. D., Lenoci, A., D’Ascenzio, M., Rodríguez, V., Filetici, P., Miceli, M., Nebbioso, A., Altucci, L., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.042 · Cited by 64
Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Oanh, D. T. K., Hai, H. V., Park, S. H., Kim, H., Han, B.-W., Kim, H.-S., Hong, J. T., Han, S., Huệ, V. T. M., & Nam, N. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.124 · Cited by 60
Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones
Kaminskyy, D. V., den Hartog, G. J. M., Wojtyra, M., Lelyukh, M. I., Gzella, A. K., Bast, A., & Lesyk, R. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.011 · Cited by 60
Li, L., Zhou, X., Ching, W., & Wang, P. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-501 · Cited by 59
Strieter, R. M. (2005) · Nature Medicine · doi:10.1038/nm0905-925 · Cited by 59
Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors
Guggilapu, S. D., Guntuku, L., Reddy, T. S., Nagarsenkar, A., Sigalapalli, D. K., Naidu, V. G. M., Bhargava, S. K., & Bathini, N. B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.025 · Cited by 59
An Update On Dual Src/Abl Inhibitors
Musumeci, F., Schenone, S., Brullo, C., & Botta, M. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.29 · Cited by 57
Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
Sebastian, A., Pandey, V., Mohan, C. D., Chia, Y. T., Rangappa, S., Mathai, J., Baburajeev, C. P., Paricharak, S., Mervin, L., Bulusu, K. C., et al. (2016) · ACS Omega · doi:10.1021/acsomega.6b00251 · Cited by 55
Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
Griffith, D. M., Parker, J. P., & Marmion, C. J. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611009050354 · Cited by 53
Cardoso, M. V. D. O., Moreira, D. R. M., Filho, G. B. O., Cavalcanti, S. M. T., Coêlho, L. C. D., Espíndola, J. W. P., Gonzalez, L. R., Rabello, M. M., Hernandes, M. Z., Ferreira, P. M. P., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.041 · Cited by 47
Tùng, T. T., Oanh, D., Dung, P. P., Huệ, V. T. M., Park, S., Han, B. W., Kim, Y. S., Hong, J. T., Han, S., & Nam, N. (2013) · Medicinal Chemistry · doi:10.2174/15734064113099990027 · Cited by 47
Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer Agents
Kryshchyshyn‐Dylevych, A., Atamanyuk, D., & Lesyk, R. (2012) · Scientia Pharmaceutica · doi:10.3797/scipharm.1204-02 · Cited by 46
Chemical Structure-Biological Activity Models for Pharmacophores’ 3D-Interactions
Putz, M. V., Duda-Seiman, C., Duda-Seiman, D., Putz, A.-M., Alexandrescu, I., Mernea, M., & Avram, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071087 · Cited by 45
Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors
Vogt, D., Weber, J., Ihlefeld, K., Brüggerhoff, A., Proschak, E., & Stark, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.044 · Cited by 43
Novel P45017α inhibitors: 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androstene derivatives
Zhu, N., Ling, Y., Lei, X., Handratta, V. D., & Brodie, A. M. H. (2003) · Steroids · doi:10.1016/s0039-128x(03)00082-5 · Cited by 42
Wang, F., Yang, Z., Liu, Y., Ma, L., Wu, Y., He, L., Shao, M., Yu, K., Wu, W., Pu, Y., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.055 · Cited by 41
New thiazole carboxamides as potent inhibitors of Akt kinases
Chang, S., Zhang, Z., Zhuang, X., Luo, J., Cao, X., Li, H., Tu, Z., Lu, X., Ren, X., & Ding, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.080 · Cited by 37
Yahya, S. M. M., Abdelhamid, A. O., Abdelhalim, M. M., Elsayed, G. H., & Eskander, E. F. (2017) · Steroids · doi:10.1016/j.steroids.2017.08.002 · Cited by 37
Suthar, S. K., Bansal, S., Lohan, S., Modak, V., Chaudhary, A., & Tiwari, A. K. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.003 · Cited by 36
Choi, M., Jung, K. H., Kim, D., Lee, H., Zheng, H., Park, B. H., Hong, S., Kim, M.-H., Hong, S., & Hong, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.005 · Cited by 36
Santos, K., Laranjo, M., Abrantes, A. M., Brito, A., Gonçalves, A. C., Sarmento‐Ribeiro, A. B., Botelho, M. F., Soares, M. I. L., Oliveira, A. S. R., & Melo, T. M. V. D. P. E. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.008 · Cited by 35
Synthesis and structure–activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors
Reichelt, A. F., Bailis, J. M., Bartberger, M. D., Yao, G., Shu, H., Kaller, M. R., Allen, J. G., Weidner, M. F., Keegan, K. S., & Dao, J. H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.013 · Cited by 35
Romagnoli, R., Baraldi, P. G., Lopez-Cara, L. C., Salvador, M. K., Bortolozzi, R., Basso, G., Viola, G., Balzarini, J. M., Brancale, A., Fu, X., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.013 · Cited by 35
Giri, R. S., Thaker, H. M., Giordano, T., Chen, B., Nuthalapaty, S., Vasu, K. K., & Sudarsanam, V. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.04.038 · Cited by 35
Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives
Luo, Y., Xiao, F., Qian, S., Lu, W. P., & Yang, B. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.014 · Cited by 34
Pejchal, V., Štěpánková, Š., Pejchalová, M., Královec, K., Havelek, R., Růžičková, Z., Ajani, H., Lo, R., & Lepšı́k, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.02.033 · Cited by 34
Salehi, M., Amini, M., Ostad, S. N., Riazi, G. H., Assadieskandar, A., Shafiei, B., & Shafiee, A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.030 · Cited by 32
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
Anandan, S., Ward, J. S., Brokx, R. D., Denny, T. A., Bray, M. R., Patel, D. V., & Xiao, X.-Y. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.050 · Cited by 32
Peptide Based Macrocycles: Selective Histone Deacetylase Inhibitors with Antiproliferative Activity
Rajak, H., Singh, A. J., Dewangan, P. K., Patel, V. S., Jain, S., Tiwari, S. K., Veerasamy, R., & Sharma, P. C. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320140006 · Cited by 32
Self-citationOptimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol
Mayhoub, A. S., Marler, L., Kondratyuk, T. P., Park, E., Pezzuto, J. M., & Cushman, M. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.047 · Cited by 31
Thompson, J., Cundliffe, E., & Stark, M. J. R. (1982) · Microbiology · doi:10.1099/00221287-128-4-875 · Cited by 31
Ewida, M. A., Ella, D. A. A. E., Lasheen, D. S., Ewida, H. A., El‐Gazzar, Y. I., & El‐Subbagh, H. I. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.08.010 · Cited by 30
Park, J.-H., & Oh, C. (2010) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2010.31.10.2854 · Cited by 29
Majeed, R., & Hamid, A. (2012) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000156 · Cited by 28
Shivaramu, P. D., KAVITHA, C. V., Vinaya, K., Ranganatha, S. R., Raghavan, S. C., & Rangappa, K. S. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.056 · Cited by 27
Afzal, O., Akhtar, M. S., Kumar, S., Ali, M. R., Jaggi, M., & Bawa, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.038 · Cited by 27
Mirza, S., Naqvi, S. A., Khan, K. M., et al. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.12.003 · Cited by 26
Ge, C., Chang, L., Zhao, Y., et al. (2017) · Molecules · doi:10.3390/molecules22020342 · Cited by 26
Xuejiao, S., Xia, Y., Ningyu, W., Zhang, L., Xuanhong, S., Xu, Y., Ye, T., Yaojie, S., Yongxia, Z., & Yu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063900 · Cited by 25
Rajak, H., Kumar, P., Parmar, P., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.058 · Cited by 23
Liang, Y., Yue, Z., Li, J., Tan, C., Miao, Z., Tan, W., & Yang, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.047 · Cited by 22
Lefranc, F., Xu, Z., Burth, P., Mathieu, V., Revelant, G., Faria, M. V. D. C., Noyon, C., Garcia, D. G., Dufour, D., Bruyère, C., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.046 · Cited by 20
Amada, H., Sekiguchi, Y., Ono, N., Koami, T., Takayama, T., Yabuuchi, T., Katakai, H., Ikeda, A., Aoki, M., Naruse, T., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.09.066 · Cited by 18
Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series
Cohen, A., Crozet, M. D., Rathelot, P., Azas, N., & Vanelle, P. (2012) · Molecules · doi:10.3390/molecules18010097 · Cited by 18
Zhou, W., Tang, W., Sun, Z., Li, Y., Dong, Y., Pei, H., Peng, Y., Wang, J., Shao, T., Jiang, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep33434 · Cited by 18
Xu, R., Tian, Y., Huang, S., Yu, J., Deng, Y., Zhan, M., Zhang, T., Wang, F., Zhao, L., & Chen, Y. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13068 · Cited by 18
Fairhurst, R. A., Gerspacher, M., Imbach, P. A., Mah, R., Caravatti, G., Furet, P., Fritsch, C. M., Schnell, C., Blanz, J., Blasco, F., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.067 · Cited by 17
Kavitha, K., Srikrishna, D., & Aparna, P. (2018) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2018.08.007 · Cited by 12
Li, Y. X., Zhai, X., Liao, W. K., Zhu, W. F., He, Y., & Gong, P. (2012) · Chinese Chemical Letters · doi:10.1016/j.cclet.2012.01.015 · Cited by 10
Jain, D. K., Patel, V. K., Singh, A., Sharma, P., Gupta, A. K., Sharma, A. K., & Rajak, H. (2014) · Cited by 8
Self-citation
Metadata
- Authors
- Sharma, P. C., Bansal, K. K., Sharma, A., Sharma, D., & Deep, A.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 188
- Pages
- 112016
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2997313217
- Cited by
- 382
- References
- 129
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.